Sarrazin C - Search Results

1

New hepatitis C therapies in clinical development.

Vermehren J, Sarrazin C. Vermehren J, et al. Among authors: sarrazin c. Eur J Med Res. 2011 Jul 25;16(7):303-14. doi: 10.1186/2047-783x-16-7-303. Eur J Med Res. 2011. PMID: 21813371 Free PMC article. Review.

2

Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses.

Sarrazin C, Herrmann E, Bruch K, Zeuzem S. Sarrazin C, et al. J Virol. 2002 Nov;76(21):11079-90. doi: 10.1128/jvi.76.21.11079-11090.2002. J Virol. 2002. PMID: 12368350 Free PMC article.

3

Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy.

Berg T, Sarrazin C, Herrmann E, Hinrichsen H, Gerlach T, Zachoval R, Wiedenmann B, Hopf U, Zeuzem S. Berg T, et al. Among authors: sarrazin c. Hepatology. 2003 Mar;37(3):600-9. doi: 10.1053/jhep.2003.50106. Hepatology. 2003. PMID: 12601358

4

Dynamics of apoptotic activity during antiviral treatment of patients with chronic hepatitis C.

Kronenberger B, Zeuzem S, Sarrazin C, Mihm U, von Wagner M, Hofmann WP, Piiper A, Herrmann E. Kronenberger B, et al. Among authors: sarrazin c. Antivir Ther. 2007;12(5):779-87. Antivir Ther. 2007. PMID: 17713161 Clinical Trial.

5

Treatment predictors of a sustained virologic response in hepatitis B and C.

Kau A, Vermehren J, Sarrazin C. Kau A, et al. Among authors: sarrazin c. J Hepatol. 2008 Oct;49(4):634-51. doi: 10.1016/j.jhep.2008.07.013. Epub 2008 Jul 31. J Hepatol. 2008. PMID: 18715665 Free article. Review.

6

Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification.

Vermehren J, Kau A, Gärtner BC, Göbel R, Zeuzem S, Sarrazin C. Vermehren J, et al. Among authors: sarrazin c. J Clin Microbiol. 2008 Dec;46(12):3880-91. doi: 10.1128/JCM.00755-08. Epub 2008 Sep 17. J Clin Microbiol. 2008. PMID: 18799708 Free PMC article.

7

Clinical relevance of the 2'-5'-oligoadenylate synthetase/RNase L system for treatment response in chronic hepatitis C.

Mihm U, Ackermann O, Welsch C, Herrmann E, Hofmann WP, Grigorian N, Welker MW, Lengauer T, Zeuzem S, Sarrazin C. Mihm U, et al. Among authors: sarrazin c. J Hepatol. 2009 Jan;50(1):49-58. doi: 10.1016/j.jhep.2008.08.024. Epub 2008 Nov 11. J Hepatol. 2009. PMID: 19022516

8

Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms.

Hofmann WP, Herrmann E, Sarrazin C, Zeuzem S. Hofmann WP, et al. Among authors: sarrazin c. Liver Int. 2008 Dec;28(10):1332-43. doi: 10.1111/j.1478-3231.2008.01896.x. Liver Int. 2008. PMID: 19055642 Review.

9

Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography.

Friedrich-Rust M, Wunder K, Kriener S, Sotoudeh F, Richter S, Bojunga J, Herrmann E, Poynard T, Dietrich CF, Vermehren J, Zeuzem S, Sarrazin C. Friedrich-Rust M, et al. Among authors: sarrazin c. Radiology. 2009 Aug;252(2):595-604. doi: 10.1148/radiol.2523081928. Radiology. 2009. PMID: 19703889

10

Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients.

Susser S, Welsch C, Wang Y, Zettler M, Domingues FS, Karey U, Hughes E, Ralston R, Tong X, Herrmann E, Zeuzem S, Sarrazin C. Susser S, et al. Among authors: sarrazin c. Hepatology. 2009 Dec;50(6):1709-18. doi: 10.1002/hep.23192. Hepatology. 2009. PMID: 19787809 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

429 results

Search Page

Filters